William Guerrant, Ph.D. - Publications

2012 Georgia Institute of Technology, Atlanta, GA 
Biochemistry, Pharmaceutical Chemistry, Oncology

11/14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Guerrant W, Kota S, Troutman S, Mandati V, Fallahi M, Stemmer-Rachamimov A, Kissil JL. YAP mediates tumorigenesis in neurofibromatosis type 2 by promoting cell survival and proliferation through a COX2-EGFR signaling axis. Cancer Research. PMID 27216189 DOI: 10.1158/0008-5472.CAN-15-1144  0.64
2014 Moleirinho S, Guerrant W, Kissil JL. The Angiomotins--from discovery to function. Febs Letters. 588: 2693-703. PMID 24548561 DOI: 10.1016/j.febslet.2014.02.006  0.64
2013 Guerrant W, Patil V, Canzoneri JC, Yao LP, Hood R, Oyelere AK. Dual-acting histone deacetylase-topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 3283-7. PMID 23622981 DOI: 10.1016/j.bmcl.2013.03.108  0.64
2012 Guerrant W, Patil V, Canzoneri JC, Oyelere AK. Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. Journal of Medicinal Chemistry. 55: 1465-77. PMID 22260166 DOI: 10.1021/jm200799p  0.64
2011 Gryder BE, Guerrant W, Chen CH, Oyelere AK. Oxathiazole-2-one derivative of bortezomib: Synthesis, stability and proteasome inhibition activity Medchemcomm. 2: 1083-1086. DOI: 10.1039/c1md00208b  0.64
2010 Mwakwari SC, Guerrant W, Patil V, Khan SI, Tekwani BL, Gurard-Levin ZA, Mrksich M, Oyelere AK. Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton Journal of Medicinal Chemistry. 53: 6100-6111. PMID 20669972 DOI: 10.1021/jm100507q  0.64
2010 Mwakwari SC, Patil V, Guerrant W, Oyelere AK. Macrocyclic histone deacetylase inhibitors. Current Topics in Medicinal Chemistry. 10: 1423-40. PMID 20536416 DOI: 10.2174/156802610792232079  0.64
2010 Guerrant W, Mwakwari SC, Chen PC, Khan SI, Tekwani BL, Oyelere AK. A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors. Chemmedchem. 5: 1232-5. PMID 20533500 DOI: 10.1002/cmdc.201000087  0.64
2010 Patil V, Guerrant W, Chen PC, Gryder B, Benicewicz DB, Khan SI, Tekwani BL, Oyelere AK. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. Bioorganic & Medicinal Chemistry. 18: 415-25. PMID 19914074 DOI: 10.1016/j.bmc.2009.10.042  0.64
2009 Oyelere AK, Chen PC, Guerrant W, Mwakwari SC, Hood R, Zhang Y, Fan Y. Non-peptide macrocyclic histone deacetylase inhibitors. Journal of Medicinal Chemistry. 52: 456-68. PMID 19093884 DOI: 10.1021/jm801128g  0.64
2008 Chen PC, Patil V, Guerrant W, Green P, Oyelere AK. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. Bioorganic & Medicinal Chemistry. 16: 4839-53. PMID 18397827 DOI: 10.1016/j.bmc.2008.03.050  0.64
Low-probability matches
2018 Kota S, Hou S, Guerrant W, Madoux F, Troutman S, Fernandez-Vega V, Alekseeva N, Madala N, Scampavia L, Kissil J, Spicer TP. A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype. Oncogene. PMID 29743592 DOI: 10.1038/s41388-018-0257-5  0.01
1957 Bartlett RW, Dollear FG, Guerrant WB, Hewlett JP, Marmor RA, Rini SJ, Tierney SE, Newby W. Report of the fat stability subcommittee of the fat analysis committee—1956: Active oxygen method for determining fat stability Journal of the American Oil Chemists Society. 34: 394-398. DOI: 10.1007/BF02637890  0.01
1949 Wiley RH, Guerrant WB. Diamides from carboxylic acids and their nitriles Journal of the American Chemical Society. 71: 981-982.  0.01
Hide low-probability matches.